A A A

Boletim Científico Diário


Educação Continuada

Boletim Científico Diário

  Imprima este artigo

19/05/2017

Protocol-driven neurological prognostication and withdrawal of life-sustaining therapy after cardiac arrest and targeted temperature management.


Resuscitation - DOI: 10.1016/j.resuscitation.2017.05.014.


Abstract

Background: Brain injury is reportedly the main cause of death for patients resuscitated after out-of-hospital cardiac arrest (OHCA). However, the majority may actually die following withdrawal of life-sustaining therapy (WLST) with a presumption of poor neurological recovery. We investigated how the protocol for neurological prognostication was used and how related treatment recommendations might have affected WLST decision-making and outcome after OHCA in the Targeted Temperature Management (TTM) trial.

Methods: Analyses of prospectively recorded data: details of neurological prognostication; recommended level-of-care; WLST decisions; presumed cause of death; and Cerebral Performance Category (CPC) 6 months following randomisation.

Results: Of 939 patients, 452 (48%) woke and 139 (15%) died, mostly for non-neurological reasons, before a scheduled time point for neurological prognostication (72hours after the end of TTM). Three hundred and thirteen (33%) unconscious patients underwent prognostication at a median 117(IQR 93-137) hours after arrest. Thirty-three (3%) unconscious patients were not neurologically prognosticated and for 2 patients (1%) data were missing. Related care recommendations were: continue in 117 (37%); not escalate in 55 (18%); and withdraw in 141 (45%). WLST eventually occurred in 196 (63%) at median day 6 (IQR 5-8). At 6 months, only 2 patients with WLST were alive and 248 (79%) of prognosticated patients had died. There were significant differences in time to WLST and death after the different recommendations (log rank <0.001).

Conclusion: Delayed prognostication was relevant for a minority of patients and related to subsequent decisions on level-of-care with effects on ICU length-of-stay, survival time and outcome.

Voltar

 

Mapa do Portal

Conheça a SBC

Associados

Serviços

Produtos

Eventos

Seções

Desenvolvido pela Diretoria de Tecnologia da SBC - Todos os Direitos Reservados
© Copyright 2017 | Sociedade Brasileira de Cardiologia | tecnologia@cardiol.br
Última atualização: 26/5/2017